Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerRIGAS, James R; LARA, Primo N.Lung cancer. 2005, Vol 50, pp S17-S24, issn 0169-5002, SUP2Conference Paper

Renal cell carcinoma: current status and future directionsMARTEL, Cynthia L; LARA, Primo N.Critical reviews in oncology/hematology. 2003, Vol 45, Num 2, pp 177-190, issn 1040-8428, 14 p.Article

Small-cell carcinoma of the urinary bladder : diagnosis and managementPAN, Chong-Xian; HONGYONG ZHANG; LARA, Primo N et al.Expert review of anticancer therapy. 2006, Vol 6, Num 12, pp 1707-1713, issn 1473-7140, 7 p.Article

Treatment of extensive small cell lung cancerDAVIES, Angela M; LARA, Primo N; LAU, Derick H et al.Hematology/oncology clinics of North America. 2004, Vol 18, Num 2, issn 0889-8588, vii, 373-385 [14 p.]Article

Evolving Epidemiologic Trends in Nonclear Cell Renal Cell Cancer: An Analysis of the California Cancer RegistryPAI, Ashok; BRUNSON, Ann; BROWN, Monica et al.Urology (Ridgewood, NJ). 2013, Vol 82, Num 4, pp 840-845, issn 0090-4295, 6 p.Article

Prostate cancer and markers of bone metabolism : diagnostic, prognostic, and therapeutic implicationsNELSON, Eric C; EVANS, Christopher P; PAN, Chong-Xian et al.World journal of urology (Print). 2007, Vol 25, Num 4, pp 393-399, issn 0724-4983, 7 p.Article

Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer : Focus on docetaxelGANDARA, David R; LARA, Primo N; GOLDBERG, Zelanna et al.Seminars in oncology. 2001, Vol 28, Num 3, pp 26-32, issn 0093-7754, SUP9Conference Paper

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancerMORTENSON, Melinda M; SCHLIEMAN, Michael G; VIRUDACHALAM, Subbulakshmi et al.Lung cancer. 2005, Vol 49, Num 2, pp 163-170, issn 0169-5002, 8 p.Article

Twenty Years Post-NIH Revitalization Act: Enhancing Minority Participation in Clinical Trials (EMPaCT): Laying the Groundwork for Improving Minority Clinical Trial Accrual: Renewing the Case for Enhancing Minority Participation in Cancer Clinical TrialsCHEN, Moon S; LARA, Primo N; DANG, Julie H. T et al.Cancer. 2014, Vol 120, Num 7, pp 1091-1096, issn 0008-543X, 6 p., SUPArticle

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non-Small-Cell Lung Cancer : Results From Southwest Oncology Group Randomized TrialsLARA, Primo N; REDMAN, Mary W; KELLY, Karen et al.Journal of clinical oncology. 2008, Vol 26, Num 3, pp 463-467, issn 0732-183X, 5 p.Article

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma: A phase I/II trial of gemcitabine, paclitaxel, and methotrexateLARA, Primo N; MEYERS, Frederick J; LAW, Lisa Y et al.Cancer. 2004, Vol 100, Num 1, pp 82-88, issn 0008-543X, 7 p.Article

Positron Emission Tomography and Improved Survival in Patients With Lung Cancer : The Will Rogers Phenomenon RevisitedCHEE, Karen G; NGUYEN, Danh V; BROWN, Monica et al.Archives of internal medicine (1960). 2008, Vol 168, Num 14, pp 1541-1549, issn 0003-9926, 9 p.Article

Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosisVINALL, Ruth L; HWA, Kimberley; GHOSH, Paramita et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 6204-6216, issn 1078-0432, 13 p.Article

Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involvedROBERTS, Peter F; STRAZNICKA, Michaela; LARA, Primo N et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 126, Num 5, pp 1597-1602, issn 0022-5223, 6 p.Conference Paper

Aurora Kinases as Anticancer Drug Targets : The development of new cytotoxic agents in clinical oncologyGAUTSCHI, Oliver; HEIGHWAY, Jim; MACK, Philip C et al.Clinical cancer research. 2008, Vol 14, Num 6, pp 1639-1648, issn 1078-0432, 10 p.Article

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinomaMACK, Philip C; GANDARA, David R; LAU, Alvin H et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 4, pp 337-348, issn 0344-5704, 12 p.Article

Predictors of Survival of Advanced Renal Cell Carcinoma : Long-Term Results From Southwest Oncology Group Trial S8949LARA, Primo N; TANGEN, Catherine M; CONLON, Sarah J et al.The Journal of urology. 2009, Vol 181, Num 2, pp 512-517, issn 0022-5347, 6 p.Article

Thymoma-associated multiorgan autoimmunity : A graft-versus-host-like diseaseWADHERA, Akhil; MAVERAKIS, Emanual; MITSIADES, Nicholas et al.Journal of the American Academy of Dermatology. 2007, Vol 57, Num 4, pp 683-689, issn 0190-9622, 7 p.Article

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approachGANDARA, David R; LARA, Primo N; LAU, Derick H et al.Lung cancer. 2001, Vol 34, pp S75-S80, issn 0169-5002, SUP3Conference Paper

Current Applications for Prostate-Specific Antigen Doubling Time. CommentariesRAMIREZ, Michelle L; NELSON, Eric C; DEVERE WHITE, Ralph W et al.European urology. 2008, Vol 54, Num 2, pp 291-302, issn 0302-2838, 12 p.Article

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibodyRICHMAN, Carol M; DENARDO, Sally J; KUKIS, David L et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5920-5927, issn 1078-0432, 8 p.Article

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer : Southwest oncology group trial S0003WILLIAMSON, Stephen K; CROWLEY, John J; LARA, Primo N et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9097-9104, issn 0732-183X, 8 p.Article

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancerMACK, Philip C; DAVIES, Angela M; LARA, Primo N et al.Lung cancer. 2003, Vol 41, pp S89-S96, issn 0169-5002, SUP1Conference Paper

Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double-blind placebo-controlled trialWANG, Stephen E; LARA, Primo N; LEE-OW, Angie et al.American journal of hematology. 2002, Vol 70, Num 3, pp 191-194, issn 0361-8609Article

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II california cancer consortium trialLARA, Primo N; GANDARA, David R; FRANKEL, Paul et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 1, pp 22-28, issn 0344-5704Article